User contributions for Andrewc072

For Andrewc072 talk block log uploads logs

A user with 116 edits. Account created on 12 March 2013.

Jump to navigation Jump to search

19:5619:56, 7 August 2024 diff hist +229‎ Multiple myeloma ‎ →‎Guidelines

18:5718:57, 29 January 2024 diff hist +44‎ Lenalidomide (Revlimid) ‎ →‎Toxicity management
18:4818:48, 29 January 2024 diff hist +1,416‎ Lenalidomide (Revlimid) ‎ →‎Toxicity management

17:3517:35, 9 January 2024 diff hist +3,614‎ Multiple myeloma, induction ‎ →‎VTD-PACE {{#subobject:539ce9|Regimen=1}}

18:5918:59, 10 August 2023 diff hist +1‎ Multiple myeloma, induction ‎ →‎Dara-RVd{{#subobject:5coba5|Regimen=1}}
16:0316:03, 10 August 2023 diff hist +638‎ Multiple myeloma, induction ‎ →‎Synopsis

22:1822:18, 8 August 2023 diff hist +1,956‎ Multiple myeloma, relapsed-refractory ‎ →‎Thalidomide monotherapy {{#subobject:ff02e1|Regimen=1}}
21:4921:49, 8 August 2023 diff hist +3,033‎ Multiple myeloma, consolidation and maintenance ‎ →‎Melphalan, then auto HSCT {{#subobject:263542|Regimen=1}}
21:4521:45, 8 August 2023 diff hist −2,975‎ Multiple myeloma, consolidation and maintenance ‎ →‎Bortezomib & Melphalan, then auto HSCT {{#subobject:9c28bc|Regimen=1}}
21:4421:44, 8 August 2023 diff hist +2,976‎ Multiple myeloma, consolidation and maintenance ‎ →‎Bortezomib & Melphalan, then auto HSCT {{#subobject:9c28bc|Regimen=1}}
21:1521:15, 8 August 2023 diff hist +1,925‎ Multiple myeloma, induction ‎No edit summary Tag: Visual edit: Switched

22:5222:52, 14 December 2020 diff hist +1‎ Multiple myeloma, relapsed-refractory ‎ →‎KRD-PACE {{#subobject:0072na|Regimen=1}}
22:5222:52, 14 December 2020 diff hist +118‎ Multiple myeloma, relapsed-refractory ‎ →‎KRD-PACE {{#subobject:0072na|Regimen=1}}
22:5122:51, 14 December 2020 diff hist 0‎ Multiple myeloma, relapsed-refractory ‎ →‎KRD-PACE {{#subobject:0072na|Regimen=1}}
22:5022:50, 14 December 2020 diff hist 0‎ Multiple myeloma, relapsed-refractory ‎ →‎KRD-PACE {{#subobject:0072na|Regimen=1}}
22:4922:49, 14 December 2020 diff hist 0‎ Multiple myeloma, relapsed-refractory ‎ →‎KRD-PACE {{#subobject:0072na|Regimen=1}}
22:4922:49, 14 December 2020 diff hist +2‎ Multiple myeloma, relapsed-refractory ‎ →‎KRD-PACE {{#subobject:0072na|Regimen=1}}
22:4822:48, 14 December 2020 diff hist +3,649‎ Multiple myeloma, relapsed-refractory ‎ →‎Relapsed or refractory, non-randomized or retrospective data

19:3719:37, 18 May 2018 diff hist −388‎ Multiple myeloma ‎ →‎Bortezomib-HyperCAD
19:3619:36, 18 May 2018 diff hist +2,353‎ Multiple myeloma ‎ →‎Bortezomib-HyperCAD
19:3119:31, 18 May 2018 diff hist +26‎ Multiple myeloma ‎ →‎Relapsed or refractory, non-randomized or retrospective data
19:2819:28, 18 May 2018 diff hist +1,962‎ Multiple myeloma ‎ →‎Hyper-CVAD {{#subobject:0df285|Regimen=1}}

02:2302:23, 18 December 2015 diff hist +1,011‎ Classical Hodgkin lymphoma ‎ →‎Relapsed/refractory

19:0719:07, 11 August 2014 diff hist −14‎ Transplant conditioning regimens ‎ →‎DHAP --> BEAC & Transplant
19:0019:00, 11 August 2014 diff hist +2,195‎ Transplant conditioning regimens ‎ →‎Autologous (auto) stem cell transplant

16:5416:54, 21 March 2014 diff hist +1,363‎ Urothelial carcinoma ‎No edit summary

04:1104:11, 25 February 2014 diff hist +9‎ Prostate cancer ‎ →‎Enzalutamide (Xtandi)

23:4723:47, 24 February 2014 diff hist +1,671‎ Gastric cancer ‎No edit summary
23:1823:18, 24 February 2014 diff hist +1,108‎ Gastric cancer ‎ →‎Perioperative chemotherapy
22:2822:28, 24 February 2014 diff hist −2‎ Prostate cancer ‎ →‎Enzalutamide (Xtandi)
22:2822:28, 24 February 2014 diff hist −244‎ Prostate cancer ‎ →‎Enzalutamide (Xtandi)
22:2722:27, 24 February 2014 diff hist +644‎ Prostate cancer ‎ →‎Enzalutamide (Xtandi)

23:0323:03, 10 January 2014 diff hist +1,081‎ Immune thrombocytopenia ‎ →‎Relapsed/Refractory

18:1418:14, 27 September 2013 diff hist 0‎ Small cell lung cancer ‎ →‎Ipilimumab + Paclitaxel & Carboplatin
18:1318:13, 27 September 2013 diff hist −2‎ Prostate cancer ‎ →‎Regimen
18:1218:12, 27 September 2013 diff hist +1,117‎ Prostate cancer ‎ →‎Immunotherapy for metastatic castrate-resistant disease
17:2617:26, 27 September 2013 diff hist −6‎ Small cell lung cancer ‎ →‎Ipilimumab + Paclitaxel & Carboplatin
17:2517:25, 27 September 2013 diff hist +1,593‎ Small cell lung cancer ‎ →‎Extensive stage

22:4022:40, 24 July 2013 diff hist +1,164‎ Hairy cell leukemia ‎ →‎Untreated
22:1722:17, 24 July 2013 diff hist +970‎ Hairy cell leukemia ‎No edit summary

04:1204:12, 4 July 2013 diff hist −1‎ Lapuleucel-T (DN24-02) ‎No edit summary
04:1104:11, 4 July 2013 diff hist +1,358‎ N Lapuleucel-T (DN24-02) ‎ Created page with "==General information== Class/mechanism: Autologous cellular immunotherapy, designed to stimulate a response against HER2/Neu receptor. Autologous peripheral blood mononuclear..."

19:5819:58, 3 July 2013 diff hist +1,146‎ N Inotuzumab ozogamicin (Besponsa) ‎ Created page with "'''In clinical trials'''. ==General information== Class/mechanism: Antibody targeting CD22, conjugated with a cytotoxic, antitumor antibiotic (calicheamicin). Inotuzumab demo..."
19:4219:42, 3 July 2013 diff hist +37‎ Pathology ‎ →‎General pathology

06:1206:12, 1 July 2013 diff hist +797‎ Acute myeloid leukemia ‎No edit summary

21:5721:57, 8 June 2013 diff hist +1,643‎ Aggressive Non-Hodgkin lymphoma ‎ →‎DLBCL, Relapsed/Refractory

16:3816:38, 31 May 2013 diff hist +946‎ Penile cancer ‎ →‎Metastatic or unresectable disease

22:1722:17, 30 May 2013 diff hist +1,259‎ Penile cancer ‎ →‎Metastatic or unresectable disease
22:0822:08, 30 May 2013 diff hist +1,209‎ Penile cancer ‎No edit summary

02:5002:50, 23 May 2013 diff hist +2,315‎ N Penile cancer ‎ Created page with "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' Is th..."

Retrieved from "https://hemonc.org/wiki/Special:Contributions/Andrewc072"